MetLife's operating engine had its best quarter in years, and almost none of it reached the reported bottom line. Net investment income rose 18.4% to $6,702 million — the highest figure in the company's quarterly series going back to early 2024 — and adjusted earnings, the measure the company uses to run its segments, climbed 15.1% to $1,604 million. Yet net income attributable to MetLife rose just 1.0%, to $736 million, and book value per share fell. The gap is not a scandal and it is not a windfall: it is what happens when a life insurer marks its bonds and its hedges to market while the liabilities those assets back sit on the balance sheet at cost.
1. Balance Sheet: Deposits Grow, Reported Equity Shrinks
1-1. Principal Asset Items
| Item | Dec 31, 2025 ($M) | Jun 30, 2026 ($M) | Change % |
|---|---|---|---|
| Fixed maturity securities, available-for-sale | 315,931 | 322,183 | +2.0% |
| Mortgage loans | 84,593 | 82,856 | −2.1% |
| Short-term investments | 3,601 | 8,016 | +122.6% |
| Total investments | 472,178 | 482,563 | +2.2% |
| Cash and cash equivalents | 22,032 | 19,301 | −12.4% |
| Premiums, reinsurance and other receivables | 49,059 | 50,635 | +3.2% |
| Deferred acquisition costs and VOBA | 21,107 | 21,571 | +2.2% |
| Goodwill | 9,613 | 9,536 | −0.8% |
| Separate account assets | 151,933 | 156,850 | +3.2% |
| Total assets | 745,166 | 759,372 | +1.9% |
The most useful number on the asset side is one that never appears as a line item. The available-for-sale bond portfolio carries an amortized cost of $347,781 million against a fair value of $322,183 million. That is an unrealized loss of $25,598 million, widened from $21,270 million at year-end — $4,328 million of fresh mark-to-market pain in six months. These bonds are held against long-dated policy liabilities, so the loss lands in other comprehensive income rather than in earnings, and it unwinds as the bonds mature at par. It is nonetheless the reason reported book value falls while earnings rise.
Short-term investments more than doubled, to $8,016 million, while cash fell $2,731 million. That is mostly a shift within the liquidity bucket, though the combined position grew $1,684 million, or 6.6%. The one genuine credit signal in the table is smaller and easier to miss: the allowance for credit losses on mortgage loans rose to $1,358 million from $1,193 million, up 13.8%, against a loan book that shrank 2.1%. Commercial property remains the place to watch.
1-2. Liabilities: Where the Growth Actually Is
Policyholder account balances — customer deposits, essentially — grew 3.6% to $245,458 million. Note 5 shows the growth is concentrated in one segment. Retirement and Income Solutions added $3,024 million of capital markets and stable value products and $2,716 million of annuities and risk solutions. Those two lines alone are $5,740 million of the $8,601 million total increase, or 67%.
Future policy benefits moved the other way, down 1.3% to $206,150 million. The decline is almost entirely Asia: whole and term life reserves fell to $8,565 million from $10,140 million, and accident and health to $6,822 million from $7,913 million. Together that is roughly $2.7 billion of the $2.7 billion total decline. Under the current US accounting standard for long-duration contracts, these liabilities are re-measured each period at the current discount rate. Higher rates and a weaker yen shrink the reported number. Policies did not lapse; the discount math changed.
Total debt — short-term, long-term, collateral financing and subordinated — rose to $20,134 million from $19,329 million. The composition matters more than the total. Subordinated debt securities jumped 24.1% to $5,144 million on $1,000 million issued during the half, while long-term debt fell to $14,244 million. That is a deliberate tilt toward hybrid instruments, which regulators and rating agencies give partial equity credit. Debt to total capital reads 42.3% on reported equity, but 30.4% if you add back the accumulated other comprehensive loss — a fairer view given that the loss is an unrealized bond mark.
1-3. Capital Structure
MetLife stockholders' equity fell 3.4%, to $27,441 million. The roll-forward is exact: $28,398 million opening, plus $1,921 million of net income, less $76 million of preferred and $755 million of common dividends, less $1,463 million of treasury stock, less $659 million of comprehensive-income deterioration, plus $75 million of paid-in capital. Buybacks and OCI together took out $2,122 million — more than a profitable half-year put in.
Book value per common share worked out to $38.47, down from $38.90. Excluding the accumulated comprehensive loss, it rose to $67.86 from $66.50, a gain of 2.0%. (Both figures are derived here by removing the $2,905 million preferred liquidation preference and dividing by shares outstanding; the 10-Q does not state them.) One measure fell, the other rose, and the second is the one management and most analysts use — because under US GAAP the bonds are fair-valued and the liabilities backing them largely are not.
There is a partial offset, and it is worth noticing. The bond portfolio's unrealized loss widened $4,328 million before tax, yet accumulated other comprehensive loss deepened only $659 million, from $18,084 million to $18,743 million. The difference comes from deferred tax and from the offsetting comprehensive-income credit on insurance liabilities re-discounted at those same higher rates, along with currency translation. The natural hedge is real. It is just incomplete.
2. Income Statement: Recurring Yield, Not an Alternatives Spike
2-1. Second-Quarter Results
| Item | Q2 2025 ($M) | Q2 2026 ($M) | Change % |
|---|---|---|---|
| Premiums | 10,810 | 11,435 | +5.8% |
| Universal life and investment-type policy fees | 1,259 | 1,372 | +9.0% |
| Net investment income | 5,661 | 6,702 | +18.4% |
| Other revenues | 679 | 845 | +24.4% |
| Net investment gains (losses) | (273) | (428) | — |
| Net derivative gains (losses) | (796) | (772) | — |
| Total revenues | 17,340 | 19,154 | +10.5% |
| Policyholder benefits and claims | 10,767 | 11,335 | +5.3% |
| Interest credited to policyholder accounts | 2,400 | 3,067 | +27.8% |
| Other expenses | 3,319 | 3,844 | +15.8% |
| Capitalization of deferred acquisition costs | (126) | (127) | — |
| Total expenses | 16,360 | 18,119 | +10.8% |
| Income before income tax | 980 | 1,035 | +5.6% |
| Net income attributable to MetLife | 729 | 736 | +1.0% |
| Adjusted earnings (segment measure) | 1,393 | 1,604 | +15.1% |
| Diluted EPS (GAAP) | $1.03 | $1.09 | +5.8% |
Adjusted earnings is MetLife's segment profit measure, and Note 2 reconciles it to net income in full. It strips out net investment gains and losses, net derivative gains and losses, market risk benefit remeasurement, and a few smaller items. Working through that bridge for the quarter: $1,604 million of adjusted earnings, less $428 million of investment losses, less $772 million of derivative losses, plus $270 million of market risk benefit gains, less $170 million of investment hedge adjustments, less $54 million of real estate depreciation, plus $95 million of other items, plus a $191 million tax benefit, equals $736 million of net income. The two loss lines — $1,200 million combined — are the whole story.
Context matters more than the single quarter here, so it is worth laying out the full run. Quarterly net investment income has gone $5,436M, $5,205M, $5,227M and $5,405M through 2024; $4,885M, $5,661M, $6,089M and $5,924M through 2025; then $5,355M and $6,702M in 2026 (2024 and 2025 fourth quarters derived from annual filings less nine-month figures). Q2 2026 is the high point of that series. On an annual basis the trend is steadier than the quarters suggest: $19,908M in 2023, $21,273M in 2024, $22,559M in 2025 (2023–2025 figures from MetLife annual and quarterly filings; 2026 quarters derived from this 10-Q) — compound growth of about 6.5% a year, and the first half of 2026, annualized, implies roughly 7% growth over full-year 2025.
The 18.4% jump in investment income still deserves scrutiny, because in most quarters a move that size means private equity and other alternatives had a good run. Here it means the opposite. MetLife disclosed variable investment income of $231 million pre-tax in its Q2 earnings release. That was above the prior-year quarter, but roughly $170 million short of the company's own quarterly guidance of about $400 million. Alternatives were a headwind, not a windfall. What drove the number instead was the recurring book: an invested asset base that grew 2.2% in the first half alone, to $482,563 million, with maturing bonds rolling into higher yields. That is far more durable than an alternatives spike, and it means a return of variable investment income toward guidance would be a tailwind from here rather than a cliff.
Set against that is the crediting line. Interest credited to policyholder accounts rose 27.8% to $3,067 million, faster than investment income itself. The net spread — investment income less interest credited — was $3,635 million, up 11.5% from $3,261 million. But a single quarter overstates the precision available here. This line swings hard: $1,674 million in Q1 2026, then $3,067 million in Q2. On the cleaner six-month view, the spread was $7,316 million against $6,499 million, up 12.6%. That is the honest number.
The six-month picture is the same shape with less noise. Revenues rose 6.5% to $38,228 million, net income attributable to MetLife rose 14.8% to $1,921 million, and diluted EPS rose 19.7% to $2.83. Two things widen EPS growth beyond profit growth. The effective tax rate fell to 23.6% from 27.8%, so pre-tax income grew 8.5% while net income grew 14.8%. And the weighted-average diluted share count fell about 4.1% year over year for the six months, to roughly 652 million from 680 million (derived from reported earnings available to common shareholders and diluted EPS). Shares outstanding fell 2.7% over the half, to 637.8 million — a different and smaller number, and not the one that drives EPS.
2-2. Segment Results: Group Benefits Carried the Quarter
| Segment | Q2 2025 adj. earnings ($M) | Q2 2026 ($M) | Change % | Q2 revenue change |
|---|---|---|---|---|
| Group Benefits | 401 | 503 | +25.4% | +1.1% |
| Retirement and Income Solutions | 370 | 377 | +1.9% | +12.4% |
| Asia | 346 | 420 | +21.4% | +5.9% |
| Latin America | 233 | 268 | +15.0% | +19.6% |
| EMEA | 100 | 108 | +8.0% | +11.9% |
| MetLife Investment Management | 54 | 57 | +5.6% | +33.5% |
| Total segment | 1,504 | 1,733 | +15.2% | +7.8% |
| Corporate & Other | (111) | (129) | — | — |
| Total adjusted earnings | 1,393 | 1,604 | +15.1% |
Segment revenue grew 7.8% and segment earnings grew 15.2% — about two units of profit for every unit of revenue. For an insurer that leverage comes from claims experience and expense discipline, not from factory utilization.
Group Benefits is the clearest case. Revenue barely moved, up 1.1%, yet earnings rose 25.4%. Premiums were roughly flat at $5,819 million against $5,801 million, while policyholder benefits, claims and dividends actually fell to $5,053 million from $5,161 million. Benefits as a share of segment premiums came in at 86.8%, against 89.0% a year earlier — a 2.1 percentage point improvement in the loss ratio. In US group life and disability that is a large move, and it accounts for most of the quarter's earnings beat. It is also the item least likely to repeat on command, since mortality and disability experience is inherently lumpy.
Retirement and Income Solutions shows the mirror image. Revenue grew 12.4% and premiums jumped 31.2% to $1,587 million, but earnings rose only 1.9% to $377 million — the flattest segment result of the quarter. Policyholder benefits in the segment climbed 20.6%, from $2,045 million to $2,466 million — adding $421 million of cost against a $377 million premium gain. The new annuity and stable value flows that generated the premium growth carry high associated benefit obligations; the volume gain wa